Figure 1

(a) Comparisons of the IMT (left) and the plaque score (right) among subjects without target organ damage (TOD), with TOD, and with associated clinical conditions. (b) Comparisons of the IMT (left) and the plaque score (right) between subjects with and without left ventricular hypertrophy, and between subjects with and without proteinuria.